News AZ's Lynparza becomes first PARP drug approved in breast can... Lynparza first in class approved in breast cancer
News AZ's asthma drug Fasenra approved in EU A further 3,400 children are eligible for treatment with Orkambi
News Lilly to research real world diabetes with digital health fi... Eli Lilly and digital health firm Livongo are to collaborate on real-world studies and develop new insights into diabetes.
News Merck/Pfizer undercut rivals with newly approved diabetes dr... Steglatro cheaper than SGLT2 rivals from AZ and Lilly/Boehringer
News Roche seizes chance for Tecentriq combo in first-line lung c... Roche chasing lucrative label extension.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
